CASPIAN: 3-Yr OS
CASPIAN: 3-Yr Survival Update of First-line Durvalumab + Tremelimumab + EP vs Durvalumab + EP vs EP Alone in Extensive-Stage SCLC

Released: September 23, 2021

Activity

Progress
1
Course Completed